Valuation: Inogen, Inc.

Market Cap 171M 150M 138M 128M 241M 16.46B 245M 1.65B 648M 8.06B 644M 630M 27.76B P/E 2026 *
-8.08x
P/E 2027 * -13.6x
Enterprise Value 171M 150M 138M 128M 241M 16.46B 245M 1.65B 648M 8.06B 644M 630M 27.76B EV / Sales 2026 *
0.46x
EV / Sales 2027 * 0.43x
Free-Float
87.36%
Yield 2026 *
-
Yield 2027 * -
1 day-3.21%
1 week-3.21%
Current month-1.86%
1 month-1.09%
3 months-0.16%
6 months-2.62%
Current year-5.80%
1 week 6.25
Extreme 6.25
6.8
1 month 6.25
Extreme 6.25
7.08
Current year 5.34
Extreme 5.3401
7.67
1 year 5.34
Extreme 5.3401
9.13
3 years 4.13
Extreme 4.13
13.33
5 years 4.13
Extreme 4.13
82.35
10 years 4.13
Extreme 4.13
287.79
Manager TitleAgeSince
Chief Executive Officer 55 10/11/2023
Director of Finance/CFO 48 06/04/2026
Chief Operating Officer 56 06/07/2026
Director TitleAgeSince
Director/Board Member 66 06/08/2014
Chairman 65 29/12/2021
Director/Board Member 59 22/03/2022
Date Insider Type Main position Quantity % Market Cap.
07-06Free

Chief Operating Officer

-130,000 0.4802%
07-01Sell

Head of Human Resources

-10,938 0.0404%
06-05Free

Director

28,081 0.1037%
Change 5-day change 1-year change 3-year change Capi.($)
-3.21%-3.21%-5.66%-28.80% 171M
-3.42%-7.18%-32.62%-17.58% 155B
-5.11%-5.40%-11.62%-9.53% 102B
-1.26%-0.72%+1.76%+57.91% 58.81B
-0.94%+5.94%+39.64%+55.35% 52.82B
-2.07%-3.61%-14.93%-41.92% 41.51B
-4.73%-10.11% - - 32.69B
-2.92%+0.75%-13.14%-46.02% 28.6B
-0.57%+0.44%+59.32%-7.14% 25.27B
-3.83%-3.09%-7.56%-8.88% 20.34B
Average -2.81%-3.24%+1.69%-5.18% 51.67B
Weighted average by Cap. -3.08%-4.32%-7.62%-1.62%

Financials

2026 *2027 *
Net sales 369M 323M 298M 276M 519M 35.47B 528M 3.56B 1.4B 17.37B 1.39B 1.36B 59.81B 397M 347M 321M 296M 558M 38.12B 568M 3.82B 1.5B 18.66B 1.49B 1.46B 64.27B
Net income -21.7M -18.96M -17.53M -16.2M -30.5M -2.08B -31.05M -209M -82.02M -1.02B -81.51M -79.71M -3.51B -13.2M -11.54M -10.66M -9.85M -18.55M -1.27B -18.89M -127M -49.89M -621M -49.58M -48.49M -2.14B
Net Debt - -
Logo Inogen, Inc.
Inogen, Inc. is a global medical technology company offering respiratory products for use in the homecare setting. The Company partners with patients, prescribers, home medical equipment providers, and distributors to make its respiratory therapy products available. It develops, manufactures, and markets respiratory health products, including portable oxygen concentrators (POCs), used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions and the Simeox product for airway clearance treatment. It also distributes the Inogen Voxi 5 stationary oxygen concentrator as well as the Aurora continuous positive airway pressure (CPAP) masks in the United States. Its proprietary Inogen One and Inogen Rove POC systems concentrate the air around the patient to offer a source of supplemental oxygen 24 hours a day, seven days a week with a battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available.
Employees
753
Date Price Change Volume
14/07/26 $6.330 -3.21% 221,185
13/07/26 $6.540 0.00% 272,341
10/07/26 $6.540 +0.15% 155,452
09/07/26 $6.530 +0.62% 123,384
08/07/26 $6.490 -0.76% 231,710
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
6.330USD
Average target price
12.67USD
Spread / Average Target
+100.11%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. INGN Stock